Browsing for a professional tool that handles particular formats can be time-consuming. Regardless of the vast number of online editors available, not all of them are suitable for AMI format, and definitely not all allow you to make adjustments to your files. To make things worse, not all of them give you the security you need to protect your devices and documentation. DocHub is an excellent answer to these challenges.
DocHub is a popular online solution that covers all of your document editing needs and safeguards your work with enterprise-level data protection. It works with different formats, including AMI, and helps you modify such paperwork quickly and easily with a rich and intuitive interface. Our tool complies with important security standards, such as GDPR, CCPA, PCI DSS, and Google Security Assessment, and keeps improving its compliance to provide the best user experience. With everything it provides, DocHub is the most reliable way to Negate frame in AMI file and manage all of your personal and business documentation, regardless of how sensitive it is.
As soon as you complete all of your alterations, you can set a password on your updated AMI to make sure that only authorized recipients can work with it. You can also save your document containing a detailed Audit Trail to find out who made what changes and at what time. Opt for DocHub for any documentation that you need to edit safely and securely. Subscribe now!
[Music] welcome to esc tv barcelona were here at the esc 2022 in barcelona and im joined here by my colleague joe young han from korea to discuss the results of the frame ami trial i am stefan james professor of cardiology upsell university in sweden jo young you presented your results yesterday you were addressing an important clinical question how we should identify lesions to revascularize in patients with multivessen disease suffering from acs stemi or non-stemi can you please briefly tell the tell us about the results of your trial yeah we compared ffa guided pci versus angiography guided pci for a treatment of non-inflammated artery lesions but the primary endpoint of our study was the composite of death mi and the repeat with vascularization so we ignored 562 patients and we randomly assigned these patients to the ffa guided pci group or angiography guided pci group in a one-ton fashion during a three and a half years median follow-up the primary endpoint occurred less frequen